Gene Expression In Pregnancies Complicated by Preeclampsia

Stopped early

Conditions studied: Preeclampsia

In brief

The purpose of this study is to figure out some of the differences in bodily function between women who have preeclampsia and those who do not. * This may eventually lead to an understanding of its cause. At this time, there is no known way to prevent preeclampsia, and the cause is not known. * The only treatment is delivery of the baby, even if it is premature, in order to decrease the risk to the mother.

Key facts

Study ID

NCT00919360

Run by

University of Rochester

People needed

125

Starts

2008-06-01

Expected to finish

2015-07-01

Last updated by the study team

2015-10-21

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Gravidas at 32-42 weeks gestation,who have preeclampsia as defined by Sibai et al, 1997.
• Control patients: Gravidas without history of hypertension of any kind, and matched to cases for parity, gestational age, labor status, maternal age, and race.

You may not qualify if…

• Prior betamethasone administration, fetal growth restriction (<3%ile), prior chronic hypertension (nonpregnant or < 20 weeks gestation any pregnancy), chorioamnionitis, major fetal anomaly or chromosome abnormality, multiple gestation, and maternal diabetes (any class except diet-controlled gestational).

Where it is running

• University of Rochester Medical Center — Rochester, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.